Retinitis pigmentosa are a diverse group of hereditary diseases that lead to incurable blindness and affect two million people worldwide. Though the causes are diverse, the manifestation of the disease is similar: highly sensitive rod photoreceptors, which allow us to see at dusk, die first and the cones that operate during daylight and are responsible for high-resolution color vision follow.
Scientists from the Friedrich Miescher Institute for Biomedical Research (FMI)say they have restored vision in retinitis pigmentosa using an archaebacterial protein, halorhodopsin. Introducing light-sensitive halorhodopsin into the remaining but nonfunctional cone photoreceptors of the retina of mice not only reactivates the cone cells’ ability to interact with the rest of the visual system, it also prompts visually guided behavior. With their collaborators in the Vision Institute of Paris, the scientists were able to validate their results in light-insensitive human retinas in vitro, which were able to respond to light again after treatment.
In their work, they were not only able to specifically produce halorhodopsin in the dormant cone cells of mice with retinitis pigmentosa, but they could also show that the cones were able to interact with the rest of the visual system. The existing network of cells was able to reproduce many of the functions of the complicated cascade of molecular events that turn a unit of light into a neuronal signal. What is more, behavioral tests indicated that the retinal information was used for visually guided behavior. The remaining cone cells are therefore an optimal target for gene-therapeutic intervention in disease where photoreceptor function is lost.
Cross section of a degenerated Retinitis pigmentosa retina. The archaebacterial halorhodopsin is produced in the remaining cone photoreceptor cells (green). Only one row of photoreceptor cells is left. In white the nuclear layers of the retina. Credit: FMI
As a first step to translate these findings to patients, together with their collaborators from the Vision Institute of Paris, the FMI group introduced the archaebacterial halorhodopsin into nonfunctional human cone cells. And these treated cones in isolated human retinas started to respond to light.
“We believe that with our gene therapeutic method we have found a powerful approach that could eventually help a subset of retinitis pigmentosa patients. Our colleagues in Paris are screening patients to determine who may benefit most from this approach,” comments Botond Roska.
Citation: Busskamp V, Duebel J, Balya D, Fradot M, Viney JT, Siegert S, Groner AC, Cabuy E, Forster V, Seeliger M, Biel M, Humphries P, Paques M, Mohand-Said S, Trono D, Deisseroth K, Sahel JA, Picaud S, Roska B.(2010) Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa. Science, DOI: 10.1126/science.1190897
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Nibiru Internet Hoax "Blood Moon" Video - Kudos To Independent For Straight Debunking Article :).
- Your Microbiome Did Not Cause Your Weight Problem
- A Great Blitz Game
- On Sexuality, You Weren't Born That Way, Says Paper
- Your Coffee Habits May Be Written In Your DNA
- Anomaly!: Book News And A Clip
- Beekeeping Fad And The Stress Of Traveling Is Harmful To Bees
- "Yes I agree, it's especially sad when very young children get worried about this stuff, when there's..."
- "LocalFluff - just to say I didn't delete your comment on Stuart's post, or hide it - it was automatically..."
- "Yes I agree. I think there is a lot of hope as well, there are many who are working to save the..."
- "Oh that was just a joke. We have a way of telling jokes in the UK that we use sometimes - a very..."
- "Kaylee, oh sorry to hear that. Yes I know what you mean, from others who are in the same situation..."
- Commonly Cited Stat of 10 Bacteria for Every 1 Human Cell Is Wrong
- Why The EpiPen And Other Generic Drugs Are So Expensive
- Latest IARC Report Connects Fatness with More Cancers
- Fact Checking Mylan Claims They Raised The EpiPen Price Because of Improvements
- I’ve Had More Exposure To Agent Orange Than Anyone: Here’s What I Know
- Brussels – a Final Destination for Medical Care